CDNA
CareDx Inc
53.80$
-0.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 66.0% | 61.8% | 34.8% | 32.0% | 62.1% | 47.4% | 74.1% | 76.5% | 71.4% | 67.2% | 71.6% | 62.2% | |
| 59.6% | 53.7% | 22.5% | 20.2% | 49.4% | 25.2% | 36.5% | 61.5% | 16.6% | 17.6% | 23.4% | 15.8% | |
| 59.6% | 53.7% | 22.5% | 20.2% | 49.4% | 25.2% | 61.0% | 61.5% | 54.0% | 50.4% | 53.1% | 42.9% | |
| 4.4% | 4.3% | 3.6% | 3.6% | 7.5% | 15.9% | 9.4% | 10.5% | 12.2% | 10.9% | 13.2% | 10.3% | |
| 1.1% | 1.4% | 7.1% | 6.6% | 3.8% | 4.0% | 2.7% | 3.0% | 3.5% | 4.2% | 4.0% | 6.5% | |
| 3.2% | 4.4% | 3.8% | 2.5% | 3.2% | 6.0% | 7.0% | 7.1% | 12.9% | – | – | – | |
| 19.6% | 21.6% | 18.0% | 14.4% | 9.2% | 15.7% | 6.5% | 6.5% | 6.9% | 8.6% | 8.2% | 9.8% | |
| 10.9% | 12.0% | 43.2% | 39.7% | 25.4% | 30.0% | 12.0% | 8.9% | 7.9% | 9.8% | 7.8% | 7.7% | |
| 32.5% | 47.0% | 74.2% | 107.1% | 26.6% | 34.8% | 24.6% | 17.8% | 20.6% | 44.0% | 22.9% | 26.7% | |
| 18.2% | 18.2% | 53.2% | 51.3% | 14.9% | 23.0% | 18.8% | 13.6% | 14.0% | 16.7% | 18.2% | 21.7% | |
| 9.9% | 5.2% | 29.9% | 18.8% | 0.1% | 2.0% | 0.6% | 0.7% | 1.0% | 1.3% | 1.2% | 1.6% | |
| 1.8% | 3.0% | 4.0% | 4.1% | 3.6% | 3.6% | 2.6% | 2.4% | 1.8% | 2.8% | 1.6% | 2.4% | |
| 8.9% | 23.2% | 1.4% | 21.9% | – | – | – | – | – | – | – | – | |
| 67.5% | 53.0% | 25.4% | -7.3% | 73.4% | 65.2% | 75.4% | 82.2% | 79.4% | 56.0% | 77.1% | 73.3% | |
| -260.7% | -311.1% | -277.0% | -320.7% | -238.6% | -220.0% | -95.7% | -67.6% | -84.8% | -145.3% | -127.5% | -178.0% | |
| 15.2% | 21.3% | 21.5% | 27.9% | 27.3% | 27.8% | 12.6% | 9.2% | 9.8% | 11.5% | 11.5% | 12.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.